Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
First Real-World Insights into Belimumab Use and Outcomes in Routine Clinical Care of Systemic Lupus Erythematosus in Germany: Results from the OBSErve Germany Study.
Rheumatol Ther. 2016 Dec;3(2):271-290. doi: 10.1007/s40744-016-0047-x. Epub 2016 Nov 1.
Rheumatol Ther. 2016.
PMID: 27804088
Free PMC article.
Understanding remission in real-world lupus patients across five European countries.
Schneider M, Mosca M, Pego-Reigosa JM, Hachulla E, Teh LS, Perna A, Koscielny V, Pike J, Lobosco S, Apolone G.
Schneider M, et al.
Lupus. 2016 Apr;25(5):505-12. doi: 10.1177/0961203315619030. Epub 2015 Dec 2.
Lupus. 2016.
PMID: 26635245
Item in Clipboard
Response to belimumab among patients with systemic lupus erythematosus in clinical practice settings: 24-month results from the OBSErve study in the USA.
Collins CE, Dall'Era M, Kan H, Macahilig C, Molta C, Koscielny V, Chang DJ.
Collins CE, et al.
Lupus Sci Med. 2016 Jan 11;3(1):e000118. doi: 10.1136/lupus-2015-000118. eCollection 2016.
Lupus Sci Med. 2016.
PMID: 26835146
Free PMC article.
Item in Clipboard
Characteristics and outcomes of patients treated with apremilast in the real world: results from the APPRECIATE study.
Augustin M, Kleyn CE, Conrad C, Sator PG, Ståhle M, Eyerich K, Radtke MA, Bundy C, Mellars L, Greggio C, Cordey M, Koscielny V, Griffiths CEM.
Augustin M, et al.
J Eur Acad Dermatol Venereol. 2021 Jan;35(1):123-134. doi: 10.1111/jdv.16431. Epub 2020 Jul 30.
J Eur Acad Dermatol Venereol. 2021.
PMID: 32279378
Item in Clipboard
Baseline characteristics and patient reported outcome data of patients prescribed etanercept: web-based and telephone evaluation.
Wade AG, Crawford GM, Pumford N, Koscielny V, Maycock S, McConnachie A.
Wade AG, et al.
BMC Med Res Methodol. 2011 Jun 14;11:91. doi: 10.1186/1471-2288-11-91.
BMC Med Res Methodol. 2011.
PMID: 21672203
Free PMC article.
Item in Clipboard
Phase III SUNBEAM and RADIANCE PART B trials for Ozanimod in relapsing multiple sclerosis demonstrate superiority versus interferon-β-1a (Avonex®) in reducing annualized relapse rates and MRI brain lesions.
Koscielny V.
Koscielny V.
Neurodegener Dis Manag. 2018 Jun;8(3):141-142. doi: 10.2217/nmt-2018-0012.
Neurodegener Dis Manag. 2018.
PMID: 29943693
Free article.
Item in Clipboard
Cite
Cite